Back to MORGAN STANLEY MORGAN STANLEY

BLTEBLTE
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in Belite Bio, Inc. ADR

MORGAN STANLEY holds 235,071 shares of BLTE (Belite Bio, Inc. ADR), worth $36.2M as of 2026-Q2. The position was increased (+16.7% shares). BLTE represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$36.2M

Current Shares

235,071

Total Value Change

+$36.2M

Total Shares Change

+234,409

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
235,071
+16.7%
$36.2M0.0%$153.99
34
2026-Q1
Increased
201,409
+619.0%
$32.1M0.0%$167.88
47
2025-Q4
Increased
28,013
+435.6%
$4.5M0.0%$160.82
43
2025-Q3
Increased
5,230
+931.6%
$387,0200.0%$73.00
26
2025-Q2
Increased
507
+60.4%
$29,2540.0%$59.04
19
2025-Q1
Decreased
316
-97.0%
$20,9250.0%$66.70
0
2024-Q4
Increased
10,618
+1503.9%
$669,9960.0%$61.97
27
2024-Q3
Decreased
662
-36.6%
$31,0340.0%$46.55
0

Other major holders of BLTE: UBS Group AG, RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used